大流行
接种疫苗
2019年冠状病毒病(COVID-19)
冠状病毒
病毒学
医学
严重急性呼吸综合征冠状病毒2型(SARS-CoV-2)
单克隆抗体
免疫系统
2019-20冠状病毒爆发
病毒
疾病
重症监护医学
免疫学
抗体
传染病(医学专业)
爆发
病理
作者
Amirhossein Sahebkar,Tannaz Jamialahmadi,Hassan Rahmoune,Paul C. Guest
标识
DOI:10.1007/978-3-031-28012-2_2
摘要
The appearance of new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants with increased infectivity and immune escape capabilities has allowed continuation of the COVID-19 pandemic for the foreseeable future. This review describes the worldwide efforts aimed at developing new vaccination and treatment strategies to keep pace with these variants as they emerge. In the case of vaccines and monoclonal antibody-based therapeutics, we describe the development of variant-specific, multivalent, and universal coronavirus directed approaches. Existing treatment approaches consist of repurposed medicines, such as antiviral compounds and anti-inflammatory agents, although efforts are underway to develop new ways of preventing or minimizing the effects of infection with the use of small molecules that disrupt binding the SARS-CoV-2 virus to host cells. Finally, we discuss the preclinical and clinical testing of natural products from medicinal herbs and spices, which have demonstrated anti-inflammatory and antiviral properties and therefore show potential as novel and safe COVID-19 treatment approaches.
科研通智能强力驱动
Strongly Powered by AbleSci AI